17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Calcitonin gene-related peptide (CGRP) is crucial in the pathophysiology of migraine. We assessed the safety, tolerability, and efficacy of ALD403, a genetically engineered humanised anti-CGRP antibody, for migraine prevention.

          Related collections

          Author and article information

          Journal
          Lancet Neurol
          The Lancet. Neurology
          1474-4465
          1474-4422
          Nov 2014
          : 13
          : 11
          Affiliations
          [1 ] Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: dodick.david@mayo.edu.
          [2 ] NIHR-Wellcome Trust Clinical Research Facility, King's College London, London, UK; Department of Neurology, University of California, San Francisco, CA, USA.
          [3 ] Department of Neurology, Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA.
          [4 ] Department of Neurology and the Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, NY, USA.
          [5 ] Danish Headache Center and Department of Neurology, Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
          [6 ] MD Clinical, Hallandale Beach, FL, USA.
          [7 ] California Medical Clinic for Headache, Santa Monica, CA, USA.
          [8 ] Women's Clinical Research Center, Seattle, WA, USA.
          [9 ] Miami Research Associates, South Miami, FL, USA.
          [10 ] Boston Clinical Trials, Boston, MA, USA.
          [11 ] Pacific Northwest Statistical Consulting, Woodinville, WA, USA.
          [12 ] Alder BioPharmaceuticals, Bothell, WA, USA.
          Article
          S1474-4422(14)70209-1
          10.1016/S1474-4422(14)70209-1
          25297013
          3d345146-0077-4865-a2f7-cbcc9285c2fa
          Copyright © 2014 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article